Anticoagulant, adverse effect: Difference between revisions
| Line 18: | Line 18: | ||
* [[Hemorrhage, due to anticoagulant or thrombolytic drug]] | * [[Hemorrhage, due to anticoagulant or thrombolytic drug]] | ||
* [[Thrombolytic drug, adverse effect]] | * [[Thrombolytic drug, adverse effect]] | ||
* Aspirin, | * [[Aspirin or other salicylate or NSAID, adverse effect]] | ||
* Adverse effects of other anti-platelet agents (e.g. clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brilinta)) | |||
Includes: | Includes: | ||
* coumadin | * coumadin | ||
* heparin | * heparin | ||
* the new oral anticoagulants (NOACs): apixaban (Eliquis), betrixaban (BevyxXa), dabigatran (Pradaxa), edoxaban (Savaysa) and rivaroxaban (Xarelto), and others will probably be created also | |||
If present also code | If present also code | ||